A detailed history of Barclays PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Barclays PLC holds 1,561,886 shares of LLY stock, worth $1.24 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,561,886
Previous 1,561,886 -0.0%
Holding current value
$1.24 Billion
Previous $1.38 Billion -0.0%
% of portfolio
0.37%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$772.14 - $960.02 $391 Million - $487 Million
-506,845 Reduced 24.5%
1,561,886 $1.38 Billion
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $27.7 Million - $34.7 Million
-38,166 Reduced 1.81%
2,068,731 $1.87 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $287 Million - $384 Million
-484,394 Reduced 18.69%
2,106,897 $1.64 Billion
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $277 Million - $326 Million
526,547 Added 25.5%
2,591,291 $1.51 Billion
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $239 Million - $329 Million
549,719 Added 36.28%
2,064,744 $1.11 Billion
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $318 Million - $425 Million
905,548 Added 148.58%
1,515,025 $711 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $283 Million - $332 Million
-909,465 Reduced 59.87%
609,477 $209 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $118 Million - $137 Million
366,307 Added 31.78%
1,518,942 $556 Million
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $95.2 Million - $108 Million
320,937 Added 38.59%
1,152,635 $373 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $99.4 Million - $117 Million
-356,733 Reduced 30.02%
831,698 $270 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $372 Million - $462 Million
-1,583,991 Reduced 57.13%
1,188,431 $340 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $197 Million - $245 Million
877,346 Added 46.3%
2,772,422 $766 Million
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $154 Million - $189 Million
693,851 Added 57.76%
1,895,076 $438 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $25.9 Million - $33.5 Million
143,363 Added 13.55%
1,201,225 $276 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $33.3 Million - $43.1 Million
202,620 Added 23.69%
1,057,862 $198 Million
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $3.15 Million - $4.17 Million
24,139 Added 2.9%
855,242 $144 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $31.5 Million - $36.4 Million
215,157 Added 34.93%
831,103 $123 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $24.5 Million - $29.4 Million
-179,319 Reduced 22.55%
615,946 $101 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $66.8 Million - $82.6 Million
-560,737 Reduced 41.35%
795,265 $110 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $17 Million - $21 Million
-158,534 Reduced 10.47%
1,356,002 $178 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $11.1 Million - $12 Million
-103,660 Reduced 6.41%
1,514,536 $169 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $42.4 Million - $49.5 Million
382,464 Added 30.95%
1,618,196 $179 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $22.1 Million - $26.1 Million
198,970 Added 19.19%
1,235,732 $160 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $34.2 Million - $38.3 Million
-322,708 Reduced 23.74%
1,036,762 $120 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $7.24 Million - $9.05 Million
84,369 Added 6.62%
1,359,470 $146 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $20.2 Million - $23.2 Million
-267,103 Reduced 17.32%
1,275,101 $109 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $31.9 Million - $37.6 Million
429,605 Added 38.61%
1,542,204 $119 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $46 Million - $49.4 Million
561,514 Added 101.89%
1,112,599 $94 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $42.5 Million - $47.1 Million
551,085
551,085 $47.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.